Abiomed Touts New Study Results, Potential To Revolutionize Heart-Attack Treatment
Executive Summary
Promising new results from a pilot study of Abiomed’s Impella device to reduce damage after myocardial infarction sets the company up to start a pivotal study, which, if successful, could change how patients are treated immediately after an attack.